Can angiotensin II receptor blockers be used in patients who have developed a cough or angioedema as a result of taking an ACE inhibitor?
Vidt
D G
DG
Department of Nephrology and Hypertension, Cleveland Clinic, Cleveland Clinic Foundation, OH 44195, USA. vidtd@ccf.org
D000179:Acrylates / Q000627:therapeutic use; D001741:Black or African American; D000799:Angioedema / Q000139:chemically induced*; D000804:Angiotensin II / Q000037:antagonists & inhibitors*; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001565:Benzoates / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003371:Cough / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use; D000077405:Irbesartan; D019808:Losartan / Q000627:therapeutic use; D008297:Male; D016032:Randomized Controlled Trials as Topic; D012737:Sex Factors; D000077333:Telmisartan; D013777:Tetrazoles / Q000627:therapeutic use; D013876:Thiophenes; D014633:Valine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000068756:Valsartan
D000179:Acrylates; D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001565:Benzoates; D001713:Biphenyl Compounds; D007093:Imidazoles; D013777:Tetrazoles; D013876:Thiophenes; D000804:Angiotensin II; C068373:eprosartan; D000068756:Valsartan; D014633:Valine; D000077405:Irbesartan; D019808:Losartan; C081643:candesartan; D000077333:Telmisartan